Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
854,72 B | 23,56% | 6/6 | 34,75% | 13,52% | 31,91% | UP |
|
Johnson & Johnson NYSE:JNJ |
581,20 B | 5,27% | 5/5 | 6,91% | -31,94% | 2,36% | UP |
|
AstraZeneca PLC LSE:AZN |
236,00 B | 8,90% | 5/6 | 11,21% | -33,84% | 9,67% | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.065,67 B | 20,54% | 5/6 | -8,58% | 66,61% | 25,36% | DOWN |
|
GSK LSE:GSK |
84,93 B | 1,19% | 2/6 | 4,12% | -25,43% | -9,65% | UP |
